Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2001
03/06/2001US6198400 Portable gas detection and/or monitoring apparatus for a hostile environment
03/06/2001US6198398 Soil moisture monitoring device
03/06/2001US6197965 Polyarylalkylamino-substitued pyridine derivatives; drugs, medicine, diagnostics
03/06/2001US6197956 Cyanine dyes and synthesis methods thereof
03/06/2001US6197948 Ribonucleic acids coding polypeptides; for the development of disease resistant plants
03/06/2001US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors
03/06/2001US6197938 Monoclonal antibody specific for 20K human growth hormone and a cell line producing the monoclonal antibody
03/06/2001US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis
03/06/2001US6197933 Human EP3, prostaglandin receptor
03/06/2001US6197931 Human marco scavenger receptor
03/06/2001US6197928 Fluorescent protein sensors for detection of analytes
03/06/2001US6197925 NF-AT polypeptides and polynucleotides
03/06/2001US6197789 Antidiabetic agents
03/06/2001US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor
03/06/2001US6197599 Method to detect proteins
03/06/2001US6197598 Devices and methods for separating cellular components of blood from liquid portion of blood
03/06/2001US6197597 Apparatus for use in immunological nucleotide sequence hybridization or hormone monitoring
03/06/2001US6197596 Monitoring and/or prognostic of antibody-mediated autoimmune diseases
03/06/2001US6197594 White trigger preparations for improving the signal detection in bioluminescent and chemiluminescent reactions
03/06/2001US6197593 Mixing sample with dye; activation with light; measuring fluorescence
03/06/2001US6197592 Clinical control materials for detection of bone resorptive markers
03/06/2001US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic
03/06/2001US6197583 Therapeutic compounds
03/06/2001US6197582 Development of human monoclonal antibodies and uses thereof
03/06/2001US6197579 Apparatus for isolating and rinsing preferential aggregates that have been separated in a aggregate traping tube without reducton in preferential cell concentration
03/06/2001US6197575 Vascularized perfused microtissue/micro-organ arrays
03/06/2001US6197568 Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms
03/06/2001US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina
03/06/2001US6197540 Preparation and stabilization of cells using aged transition metal solutions
03/06/2001US6197539 Method for preparing a stabilized blood cell preparation using aged transition metal ion solution
03/06/2001US6197538 Method of establishing the presence of specific substances in milk and an implement for applying same
03/06/2001US6197536 Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
03/06/2001US6197535 Methods for purifying and assaying a conus γ-carboxylase
03/06/2001US6197534 Exposing protein, which is capable of binding analyte in sample and has detectable quality which changes in a concentration-dependent manner when bound to analyte; then measuring change; for monitoring diabetes
03/06/2001US6197533 Minimizing interference in immunoassay of serum sample by chemically modifying arginine, histidine, lysine, threonine, or tyrosine located in active site of antibody, antigen, or fragment
03/06/2001US6197532 Measuring the amount of riboflavin carrier protein in sample by immunoassay; elevated concentration indicates breast, liver, ovarian, or endometrial cancer
03/06/2001US6197531 Detecting/monitoring human immunodeficiency virus infection by measuring expression of cd3-zeta and cd3-epsilon component of t cell receptor complexes on cells; ratio of zeta compared to epsilon is inversely correlated with infection
03/06/2001US6197530 GPR10 as a target for identifying weight modulating compounds
03/06/2001US6197528 Composition of immunotoxins and retinoids and use thereof
03/06/2001US6197527 Incubating topoisomerase with epitope, tagged nucleic acid, and modulator; adding denaturant; immobilizing nucleic acid to solid support; washing in high salt solution; contacting with label/epitope binding moiety; detecting binding
03/06/2001US6197526 Polypeptides for binding human factor VIII and fragments of human factor VIII
03/06/2001US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants
03/06/2001US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein
03/06/2001US6197523 Detecting circulating epithelial cancer cells in anticoagulated whole blood sample by using special transparent container, mixing sample with epitope labeling agents/cell morphology stains, centrifuging, and inspecting
03/06/2001US6197522 Sensitive method using sample of aqueous solution which has percentage of polymers having detectable terminus such as chain transfer agent, chain initiator, chain initiator fragment, or group attached to chain transfer agent
03/06/2001US6197521 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
03/06/2001US6197520 Using fluorescently labeled probes to identify several analytes by measuring fluorescence and correcting for temperature-dependent spectral overlap; genotyping at more than one locus
03/06/2001US6197519 Pancreas-derived serpin
03/06/2001US6197515 Molecular recognition at surfaces derivatized with self-assembled monolayers
03/06/2001US6197514 Amplification and detection of Yersinia enterocolitica
03/06/2001US6197500 For hybridization probes and amplification primers used to diagnose the presence or absence of a fragile x allele in an individual
03/06/2001US6197499 Asymmetrically amplifying dna, hybridizing in solution to a fluorescently labeled probe, separating by electrophoresis, and detecting labeled probe which indicates presence of dna sequence; nonradioactive diagnosis of hiv
03/06/2001US6197498 DNA diagnostics based on mass spectrometry
03/06/2001US6197497 Immunoassay for herpes simplex virus
03/06/2001US6197494 Includes reaction element which uses capillary action to draw predetermined volume of sample into reaction chamber
03/06/2001US6197346 Administering to mucous membranes of patients
03/06/2001US6197313 Ryegrass pollen allergen
03/06/2001US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits
03/06/2001US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease
03/06/2001US6197300 ftsZ
03/06/2001US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production
03/06/2001US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy
03/06/2001US6197281 Wet appliable, instant protection sunscreen and makeup and method of use
03/06/2001US6197278 Method of imaging cell death in vivo
03/06/2001US6197258 Detector for determining aqueous metal ion concentration including a photoluminescent label bound to an analyte binding macromolecule of human apocarbonic anhydrase or derivative
03/06/2001US6197256 Measuring buoy comprising a sample testing chamber and a settling chamber and being immersible into a body of fluid to be tested whereby the sample is drawn into the settling chamber through apertures in floor of buoy
03/06/2001US6197176 Manipulation of solid, semi-solid or liquid materials
03/06/2001US6197131 Testing susceptibility of steel to corrosion by determining characteristic a value which is function of proportion of dislocations present in lattice of steel sample subjected to hardening; determining value for second sample; comparing
03/06/2001US6197130 Providing specimen of heat treatable metallic alloy; heat treating and insonifying; monitoring changes in resulting signal over time; providing data derived from heat treating of second specimen; utilizing data to terminate treatment
03/06/2001US6197069 Adrenomedullin receptor polynucleotides
03/06/2001US6196979 Cassette and applicator for biological and chemical sample collection
03/06/2001US6196073 Hand held golf ball compression and sphericity tester
03/06/2001US6196057 Integrated multi-element lubrication sensor and lubricant health assessment
03/06/2001US6196053 Method of measuring a gas component and sensing device for measuring the gas component
03/06/2001US6196051 Apparatus for determining odor levels in gas streams
03/06/2001US6196050 Method of removing siloxanes from silicon compound gases and apparatus therefor, and siloxane content analyzing method and analyzing apparatus
03/06/2001CA2118435C Method and device for obtaining and detecting immunologically active substances from the gas phase
03/06/2001CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor
03/01/2001WO2001014888A1 Method of identifying urotensin ii receptor antagonists
03/01/2001WO2001014887A1 Method to determine progesterone in raw milk
03/01/2001WO2001014886A2 Inhibitors of binding between proteins and macromolecular ligands
03/01/2001WO2001014885A2 Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay
03/01/2001WO2001014883A1 Screening method
03/01/2001WO2001014882A1 Method of identifying properties of substance to prostaglandin d receptors
03/01/2001WO2001014881A1 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-ms immune response
03/01/2001WO2001014880A1 Method for detecting an analyte using two types of particles
03/01/2001WO2001014878A1 Method and kit for detecting betalactam-containing compounds
03/01/2001WO2001014877A2 Method of diagnosing sjogren's syndrome
03/01/2001WO2001014876A1 Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
03/01/2001WO2001014875A1 CHEWING GUM FOR MEASURING ORAL pH, METHOD OF MAKING AND KIT
03/01/2001WO2001014874A1 Method and system for electronically examining animals such as cows
03/01/2001WO2001014873A1 Gas detection system and method
03/01/2001WO2001014872A1 Hematology control and system for multi-parameter hematology measurements
03/01/2001WO2001014870A1 Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
03/01/2001WO2001014866A1 Silicon-based multisensor microsystem
03/01/2001WO2001014864A2 A gas sensor and its method of manufacture
03/01/2001WO2001014862A1 Method for determining the water purity from the gerontological point of view
03/01/2001WO2001014857A1 Method and device for objective qualitative analysis of grape must and/or wines using wideband infrared spectrometry
03/01/2001WO2001014853A1 System for processing and imaging of samples
03/01/2001WO2001014852A1 Aquatic passive sampling device and methods for its use